December 2008
Volume 8, Issue 17
OSA Fall Vision Meeting Abstract  |   December 2008
Animal models of ARMD and RPE transplant in human patients
Author Affiliations
  • Pete Coffey
    Head of Department, Ocular Biology and Therapeutics, Institute of Ophthalmology, University College London, London
Journal of Vision December 2008, Vol.8, 39. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Pete Coffey; Animal models of ARMD and RPE transplant in human patients. Journal of Vision 2008;8(17):39.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

The London Project to Cure Blindness aims to make the most of human embryonic stem cells to prevent blindness and restore sight in patients with age-related macular degeneration (AMD) by 2011. Our goal is to replace cells essential for “seeing” lost by disease at the back of the eye. We aim to repair and regenerate the aged diseased eye using human embryonic stem cells which have been transformed into the cells affected in AMD: the support cells for the photoreceptors (retinal pigment epithelium) and the photoreceptors. The cells will be surgically implanted into a clinical population of AMD patients.

Coffey, P. (2008). Animal models of ARMD and RPE transplant in human patients [Abstract]. Journal of Vision, 8(17):39, 39a,, doi:10.1167/8.17.39. [CrossRef]

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.